These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 15223651
1. Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2. Zhang H, Li Y, Li H, Bassi R, Jimenez X, Witte L, Bohlen P, Hicklin D, Zhu Z. Leuk Lymphoma; 2004 Sep; 45(9):1887-97. PubMed ID: 15223651 [Abstract] [Full Text] [Related]
2. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L, Rafii S. Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950 [Abstract] [Full Text] [Related]
3. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S. Proc Natl Acad Sci U S A; 2001 Sep 11; 98(19):10857-62. PubMed ID: 11553814 [Abstract] [Full Text] [Related]
4. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Santos SC, Dias S. Blood; 2004 May 15; 103(10):3883-9. PubMed ID: 14726393 [Abstract] [Full Text] [Related]
5. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. Kim DS, Franklyn JA, Boelaert K, Eggo MC, Watkinson JC, McCabe CJ. J Clin Endocrinol Metab; 2006 Nov 15; 91(11):4603-11. PubMed ID: 16926250 [Abstract] [Full Text] [Related]
6. Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA. Blood; 2004 Nov 01; 104(9):2893-902. PubMed ID: 15238424 [Abstract] [Full Text] [Related]
11. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation. Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, Mariani G, Laufer S, Sargiacomo M, Testa U. Br J Haematol; 2009 May 01; 145(3):399-411. PubMed ID: 19245429 [Abstract] [Full Text] [Related]
12. Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line. Coppola S, Narciso L, Feccia T, Bonci D, Calabrò L, Morsilli O, Gabbianelli M, De Maria R, Testa U, Peschle C. Cell Death Differ; 2006 Jan 01; 13(1):61-74. PubMed ID: 15962006 [Abstract] [Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas. Revoltella RP, Menicagli M, Campani D. Cytokine; 2012 Mar 01; 57(3):347-59. PubMed ID: 22200506 [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D. Oncogene; 2005 Dec 01; 24(54):8025-37. PubMed ID: 16116481 [Abstract] [Full Text] [Related]
15. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Millanta F, Silvestri G, Vaselli C, Citi S, Pisani G, Lorenzi D, Poli A. Res Vet Sci; 2006 Dec 01; 81(3):350-7. PubMed ID: 16556453 [Abstract] [Full Text] [Related]
16. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA, Rafii S. J Clin Invest; 2000 Aug 01; 106(4):511-21. PubMed ID: 10953026 [Abstract] [Full Text] [Related]